- The anticipated EPS of $0.27 represents a 25% decline from the same period last year.
- Projected revenue is expected to rise by 2.3%, reaching $2.73 billion.
- The company’s financial metrics indicate a complex valuation picture, with a negative P/E ratio but potentially undervalued based on sales and cash flow.
Owens & Minor, Inc. (NYSE: OMI) is a healthcare logistics company that provides supply chain services to healthcare providers and manufacturers. The company is set to release its quarterly earnings on Monday, August 11, 2025. Analysts expect earnings per share (EPS) to be $0.27, with projected revenue of approximately $2.73 billion for the quarter.
The anticipated EPS of $0.27 represents a 25% decline from the same period last year. Despite this drop, revenues are expected to rise by 2.3%, reaching $2.73 billion. This increase in revenue suggests that while profitability may be challenged, the company is still growing its sales. The stability in the consensus EPS estimate over the past 30 days indicates that analysts have maintained their initial projections, which can influence investor reactions and stock price movements.
Owens & Minor’s low price-to-sales ratio of 0.045 suggests the stock might be undervalued relative to its sales. Similarly, the enterprise value to sales ratio of 0.074 points to a potentially undervalued position in terms of enterprise value. The enterprise value to operating cash flow ratio is 4.45, indicating a reasonable valuation based on cash flow. The debt-to-equity ratio of 0.65 shows a moderate level of debt relative to equity, while the current ratio of 1.13 suggests that Owens & Minor has slightly more than adequate current assets to cover its current liabilities.
